Naresh Nivedita K, Ben-Mordechai Tamar, Leor Jonathan, Epstein Frederick H
Department of Biomedical Engineering, University of Virginia, 480 Ray C. Hunt Drive, Charlottesville VA, 22908.
Curr Cardiovasc Imaging Rep. 2011 Feb 1;4(1):63-76. doi: 10.1007/s12410-010-9058-0.
The progression from acute myocardial infarction (MI) to heart failure continues to be a major cause of morbidity and mortality. Potential new therapies for improved infarct healing such as stem cells, gene therapy, and tissue engineering are being investigated. Noninvasive imaging plays a central role in the evaluation of MI and infarct healing, both clinically and in preclinical research. Traditionally, imaging has been used to assess cardiac structure, function, perfusion, and viability. However, new imaging methods can be used to assess biological processes at the cellular and molecular level. We review molecular imaging techniques for evaluating the biology of infarct healing and repair. Specifically, we cover recent advances in imaging the various phases of MI and infarct healing such as apoptosis, inflammation, angiogenesis, extracellular matrix deposition, and scar formation. Significant progress has been made in preclinical molecular imaging, and future challenges include translation of these methods to clinical practice.
从急性心肌梗死(MI)发展为心力衰竭仍然是发病和死亡的主要原因。诸如干细胞、基因治疗和组织工程等用于改善梗死愈合的潜在新疗法正在研究中。非侵入性成像在MI和梗死愈合的评估中,无论是临床还是临床前研究都起着核心作用。传统上,成像已被用于评估心脏结构、功能、灌注和存活能力。然而,新的成像方法可用于在细胞和分子水平评估生物学过程。我们综述了用于评估梗死愈合和修复生物学的分子成像技术。具体而言,我们涵盖了MI和梗死愈合各个阶段成像的最新进展,如细胞凋亡、炎症、血管生成、细胞外基质沉积和瘢痕形成。临床前分子成像已取得重大进展,未来的挑战包括将这些方法转化为临床实践。